bromopyruvate has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abd-Allah, AA; Ahmed, AS; Ahmed, NS; Amer, WH; El Sayed, SM; Hamed, AR; Helmy Nabo, MM; Mahmoud, AG; Mohamed, WG; Seddik, MA | 1 |
| Morinobu, A; Nishimura, K; Okano, T; Saegusa, J; Sendo, S; Takahashi, S; Ueda, Y | 1 |
1 review(s) available for bromopyruvate and Disease Exacerbation
| Article | Year |
|---|---|
Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study.
Topics: Acetaminophen; Adult; Carcinoma, Hepatocellular; Disease Progression; Drug Therapy, Combination; Enzyme Inhibitors; Glutathione; Glycolysis; Hexokinase; Humans; L-Lactate Dehydrogenase; Lactic Acid; Lung Neoplasms; Male; Melanoma; Necrosis; Neovascularization, Pathologic; Pleural Neoplasms; Prognosis; Pyruvates; Treatment Outcome | 2014 |
1 other study(ies) available for bromopyruvate and Disease Exacerbation
| Article | Year |
|---|---|
3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17/Treg cell differentiation and suppressing dendritic cell activation.
Topics: Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Autoimmune Diseases; Cell Differentiation; Dendritic Cells; Disease Models, Animal; Disease Progression; Hexokinase; Lymphocyte Activation; Lymphocyte Count; Mice; Pyruvates; Synovial Membrane; T-Lymphocytes, Regulatory; Th17 Cells | 2017 |